Sanofi-Aventis Groupe
Industry / private company
Location:
Paris,
France (FR)
ISNI: -
ROR: https://ror.org/02n6c9837
Show on Map:
Protection from cytomegalovirus viremia following glycoprotein B vaccination is not dependent on neutralizing antibodies (2018)
Baraniak I, Kropff B, Ambrose L, Mcintosh M, Mclean GR, Pichon S, Atkinson C, et al.
Journal article
Epitope-Specific Humoral Responses to Human Cytomegalovirus Glycoprotein-B Vaccine With MF59: Anti-AD2 Levels Correlate With Protection From Viremia (2018)
Baraniak I, Kropff B, Mclean GR, Pichon S, Piras-Douce F, Milne RSB, Smith C, et al.
Journal article
A DREAM challenge to build prediction models for short-term discontinuation of docetaxel in metastatic castration- resistant prostate cancer (2017)
Seyednasrollah F, Wang T, Piccolo SR, Vega R, Greiner R, Fuchs C, Gofer E, et al.
Journal article
The "Sarcopenia and Physical fRailty IN older people: multi-componenT Treatment strategies" (SPRINTT) randomized controlled trial: design and methods (2017)
Landi F, Cesari M, Calvani R, Cherubini A, Di Bari M, Bejuit R, Mshid J, et al.
Journal article
Sarcopenia: An Undiagnosed Condition in Older Adults. Current Consensus Definition: Prevalence, Etiology, and Consequences. International Working Group on Sarcopenia (2011)
Fielding RA, Vellas B, Evans WJ, Bhasin S, Morley JE, Newman AB, Van Kan GA, et al.
Journal article